CINECA IRIS Institutional Research Information System

GADDUCCI, ANGIOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 42.553
AS - Asia 30.945
EU - Europa 23.536
SA - Sud America 3.327
AF - Africa 539
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 17
Totale 100.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 40.791
CN - Cina 9.898
IT - Italia 9.500
SG - Singapore 9.093
HK - Hong Kong 4.574
SE - Svezia 2.872
BR - Brasile 2.791
KR - Corea 2.303
VN - Vietnam 2.014
UA - Ucraina 1.997
BG - Bulgaria 1.981
CA - Canada 1.495
DE - Germania 1.333
GB - Regno Unito 1.165
TR - Turchia 1.145
FR - Francia 1.144
FI - Finlandia 1.002
CH - Svizzera 902
RU - Federazione Russa 872
IN - India 432
JP - Giappone 375
BD - Bangladesh 209
AR - Argentina 192
NL - Olanda 145
IQ - Iraq 142
MX - Messico 111
ES - Italia 103
ZA - Sudafrica 100
PK - Pakistan 92
SA - Arabia Saudita 92
ID - Indonesia 90
BE - Belgio 89
VE - Venezuela 80
UZ - Uzbekistan 72
AT - Austria 70
MA - Marocco 65
EC - Ecuador 64
CO - Colombia 63
CI - Costa d'Avorio 61
PL - Polonia 57
SN - Senegal 47
PH - Filippine 45
IE - Irlanda 44
KE - Kenya 44
NG - Nigeria 43
CZ - Repubblica Ceca 39
JO - Giordania 39
EG - Egitto 38
BJ - Benin 35
RO - Romania 35
PY - Paraguay 34
CL - Cile 31
AE - Emirati Arabi Uniti 30
MY - Malesia 30
PT - Portogallo 28
AU - Australia 27
IL - Israele 27
JM - Giamaica 27
TT - Trinidad e Tobago 26
BO - Bolivia 25
NP - Nepal 25
TN - Tunisia 25
CR - Costa Rica 22
GR - Grecia 22
HU - Ungheria 22
OM - Oman 22
UY - Uruguay 21
AZ - Azerbaigian 19
LB - Libano 19
PE - Perù 19
TH - Thailandia 19
TW - Taiwan 18
DO - Repubblica Dominicana 16
DZ - Algeria 16
AL - Albania 15
EE - Estonia 15
ET - Etiopia 15
IR - Iran 15
KG - Kirghizistan 15
LT - Lituania 15
HN - Honduras 14
KZ - Kazakistan 14
RS - Serbia 13
DK - Danimarca 10
EU - Europa 10
GT - Guatemala 10
HR - Croazia 10
PA - Panama 9
KW - Kuwait 8
QA - Qatar 8
AO - Angola 7
PS - Palestinian Territory 7
BH - Bahrain 6
CY - Cipro 6
MN - Mongolia 6
NZ - Nuova Zelanda 6
AM - Armenia 5
BB - Barbados 5
GY - Guiana 5
LK - Sri Lanka 5
Totale 100.809
Salva come PNG Salva come JPEG
Città #
Singapore 5.230
Hong Kong 4.525
Ashburn 4.409
Milan 3.782
Chandler 3.225
Hefei 3.192
Jacksonville 2.701
Woodbridge 2.682
Ann Arbor 2.524
San Jose 2.319
Seoul 2.296
Fairfield 2.246
Dallas 2.151
Sofia 1.975
Houston 1.943
Shanghai 1.559
Ottawa 1.360
Beijing 1.312
New York 1.178
Santa Clara 1.037
Seattle 1.008
Wilmington 881
Boardman 865
Bern 845
Princeton 800
Lawrence 775
Nanjing 772
Cambridge 684
Lauterbourg 668
Izmir 632
Des Moines 620
Medford 593
Los Angeles 571
Dearborn 502
Jüchen 475
Ho Chi Minh City 464
Rome 387
Istanbul 378
Buffalo 363
Tokyo 341
Dong Ket 330
Hanoi 322
Nanchang 265
Helsinki 257
Redwood City 225
Council Bluffs 211
São Paulo 205
Kunming 200
San Diego 170
Boulder 154
Redondo Beach 152
Shenyang 134
Orem 131
Ogden 130
Frankfurt am Main 128
Changsha 114
Tianjin 113
Florence 110
Hebei 108
Munich 108
London 106
Jiaxing 91
Chicago 87
Brussels 85
Verona 84
Da Nang 83
Lancaster 81
Norwalk 77
Rio de Janeiro 76
Orange 75
Serra 72
Tashkent 68
Chennai 65
Düsseldorf 64
Guangzhou 64
Pune 63
The Dalles 62
Hangzhou 61
Abidjan 60
Belo Horizonte 60
Baghdad 59
Columbus 59
Brasília 58
Turin 57
Pisa 56
Dhaka 55
Vienna 52
Fuzhou 47
Curitiba 46
Dakar 46
Haiphong 44
Porto Alegre 43
Changchun 42
Detroit 42
Falls Church 42
Jinan 42
Manchester 42
Nuremberg 42
Washington 42
Riyadh 40
Totale 70.277
Salva come PNG Salva come JPEG
Nome #
Chemioterapia con CTX,DDP,ADM nel carcinoma ovarico in stadio avanzato 1.892
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 949
Isterectomia radicale secondo Wertheim-Meigs e radioterapia transcutanea postoperatoria con alte energie nel trattamento del carcinoma cervicale negli stadi Ib-II FIGO 414
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 318
Alfa2-macroglobulina e dismetabolismo glicidico in gravidanza 260
Chemioterapia neoadiuvante con schema PVB nel carcinoma cervicale avanzato. 251
A comparison of several tumor markers in the diagnosis, monitoring and follow-up of patients with epithelial ovarian cancer 249
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 229
Endometrial stromal sarco¬ma: Analysis of treatment failures and survival 223
D-dimer in gynecological cancer 218
Il recettore solubile dell' interleuchina-2(sIL-2r) nel carcinoma ovarico 218
Functional Interaction Between BRCA1 and DNA Repair in Yeast May Uncover a Role of RAD50, RAD51, MRE11A, and MSH6 Somatic Variants in Cancer Development. 218
Carboplatin, doxorubicin and cyclophosphamide versus cisplatin, doxorubicin and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma. 212
Combined use of CA125 and CA15-3 in patients with endometrial carcinoma. 212
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit? 211
Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer 210
Computerized tomography (CT) semeiotics in the presurgical evaluation of gynaecological neoplasias. 208
Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy. 207
Computed tomography in the follow-up of gynaecological neoplasias 206
Porphyrin-sensitized phototreatment as a conservative therapy in gynaecological oncology 205
Il dosaggio sierico del recettore solubile della interleuchina-2 nelle neoplasie ginecologiche 204
La tomografia assiale computerizzata nel follow-up delle pazienti precedentemente trattate per neoplasie della cervice e del corpo uterino 202
Wertheim's radical hysterectomy with pelvic lymphadenectomy in the treatment of cervical carcinoma at the Obstetric and Gynecological Clinic of the University of Pisa 198
Prospective multicenter study on CA 125 in postmenopausal pelvic masses. 198
Valutazione del CA125, TPA, GICA, CEA nella diagnosi e nel monitoraggio del carcinoma ovarico. 197
Carcinoma developing in bladder exstrophy. Case report. 197
p53 nuclear accumulation in adenomatous hyperplasia and stage I endometrioid carcinoma. 196
An analysis of approaches to the management of endome¬trial cancer in North America: A CTF study. 195
Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer 195
Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: An Italian multicenter retrospective study (CTF study) 195
Micro-RNAs and ovarian cancer: The state of art and perspectives of clinical research 194
Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma 192
Follow-up strategies in gynecological oncology: searching appropriateness 191
Factors in malignant transformation of ovarian endometriosis: A narrative review 190
Brenner's tumor 190
A comparison of the usefullness of serum measurements of CA125, CA50 and TATI in patients with malignant and benign gynecological pathology 190
Prothrombin fragment F 1+ 2 and thrombin- antithrombin III complex (TAT) plasma levels in patients with gynecological cancer 189
The role of the French-Italian glossary of complications in the outcome evaluation of cervical cancer treatment: an Italian multicentric study 188
Novel targeted therapies in epithelial ovarian cancer: from basic research to the clinic 187
Prognostic role of immunosuppres¬sive acidic protein in advanced ovarian cancer. 186
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest 186
Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research 184
The therapy of verrucous carcinoma of the vulva. Observations on three cases. 183
Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study 183
Evaluation of the central dopaminergic activity in gestational hyperprolactinaemia by means of the electroretinographic technique 181
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis 181
Metabolismo glicidico ed emoglobina glicosilata (HbA1) in gravidanza 180
First-line chemothe¬rapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients 180
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. 180
Discontinuation of modern hormonal contraceptives: an Italian survey 180
Adjuvant treatment of stage I-II malignant mixed mesodermal tumors (MMMT) of the uterus: a multicenter CTF study 179
Current management of fallopian tube carcinoma 179
Aspetti colposcopici, citologici, e istologici dell'endometriosi cervicale. 178
Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study) 178
Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature 178
Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: A debated clinical issue 178
Serum solule interleukin-receptor (sIL-2R) assay in cervical an endometrial cancer. Preliminary data. 177
Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center 177
Iperprolattinemia e stati depressivi 176
Fattori prognostici nei tumori misti mulleriani maligni (MMMT) dell' utero al I-II stadio: uno studio CTF 176
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature 176
Adjuvant treatment of early stage ovarian carcinoma. 175
Assenza di alterazioni dell'oncogene MDM-2 nel carcinoma ovarico 175
The role of computerized tomography of the pelvis in the presurgical staging of carcinoma of the cervix and of the ovary Eur.J. Gynaec. 174
Factor VIIIR: Ag plasma levels in patients with cervical and ovarian carcinoma 174
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. 174
Struma ovarii 173
Uterine leiomyosarcoma: Analysis of treatment failures and survival 173
Pharmacological treatment for uterine leiomyosarcomas 173
A combination of CA125, CA19-9, CA15-3, CA50, CA72-4 and TATI in the monitoring of ovarian carcinoma 172
Epidoxorubicin (EPI-DX) and lonidamine (LND) in refractory or recurrent epithelial ovarian cancer (EOC) 172
Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study 172
Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer 172
Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer. 172
Weekly epirubicin in the treatment of gestational breast cancer (GBC) 172
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 172
A comparative evaluation of the ability of serum CA125, CA19-9, CA15-3, CA50, CA72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma 171
Surgery and radiotherapy in the treatment of early stage uterine sarcomas. 171
Preoperative evaluation of D-Dimer and CA 125 levels in differentiating benign from malignant ovarian masses. 171
Presidi farmacologici nel controllo dell'emesi indotta dalla chemioterapia per neoplasie maligne ginecologiche 170
Sistema immunitario e carcinoma ovarico 170
The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients 170
Minimization of cisplatin nephrotoxicity in high-risk patients 170
Le complicanze postoperatorie dell'intervento di laparoisterectomia radicale con linfadenectomia pelvica 169
Porfirine e luce visibile nella diagnosi e nella terapia delle neoplasie. Prime esperienze cliniche in oncologia ginecologica. 168
The topical administration of steroids in the treatment of typical vulvar dystrophy. 168
Carcinosarcoma of the uterus : a clinicopathological multicenter CTF study 168
Management of borderline ovarian tumors: Results of an Italian multicenter study 168
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma. 167
Evaluation of FHIT gene alterations in ovarian cancer 167
Squamous cell carcinoma of the vagina: Natural history, treatment modalities and prognostic factors 167
Colposcopic, cytologic and histologic aspects of cervix uteri in adolescents. 166
Verrucous carcinoma of the cervix 166
Iperespressione della proteina p53 nella iperplasia endometriale e nel carcinoma endonmetriale in I stadio 166
P53 overexpression in ovarian cancer: correlation with clinicopathological parameters and chemosensitivity 166
Analysis of failures in patients with stage I ovarian cancer: an Italian multicenter study 166
Prognostic factors in uterine sarcoma 166
Fertility drug use and risk of ovarian tumors: a debated clinical challenge 166
Hemorrhagic uterine necrosis after surgical vessel ligation and B-Lynch suture in persistent post-cesarean uterine atony: case report and review of literature 166
Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS) 166
Totale 21.378
Salva come PNG Salva come JPEG
Categoria #
all - tutte 268.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 268.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.131 0 0 0 0 0 0 0 0 0 0 277 854
2021/20227.668 194 545 307 678 1.516 1.000 189 360 281 148 344 2.106
2022/20238.048 1.124 683 424 699 1.172 1.282 115 727 1.124 58 531 109
2023/202410.127 1.958 1.282 1.654 828 1.404 1.301 266 302 169 121 135 707
2024/202521.707 149 1.021 226 1.116 958 1.255 1.727 1.287 2.161 2.959 3.334 5.514
2025/202622.875 1.864 4.439 3.375 1.856 1.681 2.376 3.419 992 942 1.897 34 0
Totale 101.514